Shay Capital »

Neuphoria Therapeutics shares owned by Shay Capital

Quarter-by-quarter ownership of Neuphoria Therapeutics (NEUP) shares owned by Shay Capital from 13F filings

Historical chart of Shay Capital investment in Neuphoria Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Neuphoria Therapeutics held by Shay Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neuphoria Therapeutics by Shay Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $615k 151k 4.07

More positions owned by Shay Capital

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Ftai Aviation SHS (FTAI)
Purecycle Technologies (PCT)
Meta Platforms Cl A (META)
Micron Technology (MU)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Ishares Tr Russell 2000 Etf (IWM)
Thermo Fisher Scientific (TMO)
Papa John's Int'l (PZZA)
Celsius Hldgs Com New (CELH)
Intel Corporation (INTC)
Golar Lng SHS (GLNG)
Core Scientific (CORZ)
Amazon (AMZN)

View all positions for Shay Capital

Top funds holding Neuphoria Therapeutics

Lynx1 Capital Management
AdvisorShares Investments
Shay Capital
Balyasny Asset Management
Squadron Capital Management
Geode Capital Management
Diadema Partners
Ikarian Capital
Vanguard Fiduciary Trust
ADAR1 Capital Management
FNY Investment Advisers
Vanguard Group
Citadel Advisors
Bridgeway Capital Management
Boothbay Fund Management

View all funds holding Neuphoria Therapeutics